Microbiology

Items 3751-3800 of 6345

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Antibacterial Agent

    Pectin is a heteropolysaccharide primarily derived from the cell walls of higher plants, functioning as an effective antibacterial agent. It exhibits broad-spectrum antimicrobial activity, binding to bacterial toxins and irritants in the intestinal mucosa, thereby alleviating mucosal irritation. Additionally, pectin serves as a versatile agent for the formation of nanoparticles, facilitating the delivery of therapeutic compounds. Its properties make it valuable for research in gastrointestinal health and drug delivery systems.
  2. Antibiotic

    Virginiamycin M1 is a polyunsaturated macrocyclic lactone antibiotic derived from Streptomyces virginiae. It exhibits significant antibacterial activity against Staphylococcus aureus, with a minimal inhibitory concentration (MIC) of 0.25 μg/mL. This compound is commonly utilized in research applications to investigate antibiotic mechanisms and resistance, as well as for the study of bacterial pathogens.
  3. Antibiotic

    Framycetin sulfate, an aminoglycoside antibiotic, primarily targets RNase P, functioning as a potent inhibitor of its cleavage activity with a Ki of 35 μM. It competes for divalent metal ion binding sites within RNase P RNA, effectively inhibiting the hammerhead ribozyme with a Ki of 13.5 μM. Additionally, as a 5″-azido neomycin B precursor, Framycetin sulfate binds to the Drosha site in miR-525, making it applicable in the study of hepatic encephalopathy and enteropathogenic E. coli infections.
  4. Antibiotic

    Nemadectin is an orally active broad-spectrum endectocide that targets gastrointestinal helminths. It demonstrates potent anthelmintic activity, making it effective against natural infections in canines caused by major helminth species. This compound is valuable for research applications focused on parasitic infections and the development of novel anthelmintic therapies.
  5. Antibiotic

    Kanamycin sulfate is a broad-spectrum aminoglycoside antibiotic that primarily targets bacterial protein synthesis by binding to the 30S ribosomal subunit. This reagent is effective against a range of bacterial infections, particularly those caused by certain staphylococci and Gram-negative bacilli. However, caution is advised due to its potential ototoxic effects. Kanamycin sulfate is commonly utilized in microbiological research and treatment protocols for severe bacterial infections.
  6. Antibiotic

    Cefpodoxime is a broad-spectrum antibiotic that exhibits activity against a variety of gram-positive and gram-negative bacteria. Its primary mechanism of action involves inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Cefpodoxime is useful for research applications related to acute otitis media, sinusitis, and tonsillopharyngitis, enabling investigations into microbial resistance and treatment efficacy.
  7. Tetracycline Antibiotic

    Demeclocycline is an orally active tetracycline antibiotic that targets bacterial protein synthesis. It functions by binding to the 30S ribosomal subunit, effectively inhibiting the binding of aminoacyl-tRNA. Demeclocycline demonstrates antibacterial activity against a broad spectrum of bacterial infections and is utilized in various research applications related to antibiotic resistance and microbial pathogenesis.
  8. Antibiotic

    Gentamicin C1a is an aminoglycoside antibiotic that primarily targets bacterial ribosomes, inhibiting protein synthesis. As the major component of the Gentamicin complex, it exhibits significant antibacterial activity against a wide range of Gram-negative and some Gram-positive bacteria. Gentamicin C1a is commonly employed in microbiological research and clinical studies to evaluate antibacterial efficacy and resistance mechanisms.
  9. Antibiotic Agent

    Cloxacillin sodium is a β-lactam antibiotic and a potent β-lactamase inhibitor with an IC50 of 0.04 µM. It exhibits significant antibacterial activity, particularly against Staphylococcus aureus, and can effectively attenuate the S. aureus-induced inflammatory response by inhibiting the activation of MAPK, NF-κB, and NLRP3-related proteins. This compound is relevant for research in antimicrobial resistance and inflammation pathways.
  10. Antibiotic

    Lefamulin is an orally active antibiotic that primarily targets bacterial protein synthesis by binding to the peptidyl transferase center of the 50S ribosomal subunit. This binding effectively inhibits the formation of peptide bonds, leading to disruption of bacterial growth. In addition to its antimicrobial properties, Lefamulin exhibits anti-inflammatory activity. It is valuable for research applications focused on bacterial infections, including conditions such as bacterial pneumonia.
  11. Antibiotic

    Amoxicillin-clavulanate potassium is a combination antibiotic that targets bacterial cell wall synthesis and inhibits beta-lactamase enzymes. It exhibits broad-spectrum antibacterial activity against a variety of Gram-positive and Gram-negative pathogens. This reagent is commonly utilized in research to study bacterial infections and evaluate potential therapeutic strategies for combating antibiotic resistance.
  12. Antibiotic

    Contezolid is an orally active oxazolidinone antibiotic targeting resistant Gram-positive bacteria. It demonstrates significant efficacy against complicated skin and soft tissue infections (cSSTI) while exhibiting a reduced risk of myelosuppression and minimal monoamine oxidase inhibition. This unique profile makes Contezolid a promising candidate for the treatment of infections caused by resistant strains.
  13. Antibacterial Agent

    Ceftolozane is a cephalosporin antibiotic that specifically targets bacterial infections by inhibiting cell wall synthesis. It exhibits potent antibacterial activity against Pseudomonas aeruginosa and various Enterobacteriaceae strains, with minimal inhibitory concentrations (MICs) reported at 0.5 mg/L and 0.25-0.5 mg/L, respectively. This reagent is valuable for research applications focused on antibiotic resistance and the development of new therapeutic strategies.
  14. Antibiotic

    Mupirocin lithium is an antibiotic that targets bacterial isoleucyl-tRNA synthetase, effectively inhibiting protein synthesis. This compound exhibits potent activity against a range of Gram-positive bacteria, including Staphylococcus and Streptococcus, as well as certain Gram-negative strains such as Haemophilus influenzae. Mupirocin lithium is utilized in research focused on skin infections, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA), and chronic sinusitis.
  15. Antibiotic

    Ramoplanin is a broad-spectrum lipoglycodepsipeptide antibiotic that targets gram-positive bacteria. Derived from Actinoplanes species, it exhibits potent antimicrobial activity, making it effective against various resistant strains. This compound is significant for research applications focusing on antibiotic resistance mechanisms and the development of novel antimicrobial therapies.
  16. Antibiotic

    Hygromycin A is a spirochete-specific antibiotic targeting Borrelia burgdorferi, the causative agent of Lyme disease. It exhibits potent antibacterial activity against spirochetes, making it a valuable tool for research into Lyme disease and gut health. Hygromycin A is suitable for studies investigating spirochete pathogenesis and potential therapeutic interventions.
  17. Antibiotic

    Cefetamet is a cephalosporin antibiotic that functions by binding to bacterial penicillin-binding proteins (PBPs), with an IC50 of 2.5 μg/mL for PBP3 in Escherichia coli W3110. It exhibits significant antibacterial activity against a variety of Gram-negative bacteria, including Enterobacteriaceae, Neisseria species, and Haemophilus influenzae, as well as Gram-positive bacteria such as Streptococcus. Additionally, Cefetamet demonstrates bactericidal effects against Treponema pallidum. This compound is valuable for researching respiratory, urinary, and ear, nose, and throat infections, in addition to syphilis.
  18. Antibiotic Agent

    Oxytetracycline hydrochloride is an antibiotic from the tetracycline class, primarily targeting bacterial protein synthesis. It effectively inhibits both Gram-negative and Gram-positive bacteria by preventing the binding of aminoacyl-tRNA to the mRNA-ribosomal RNA complex. Additionally, oxytetracycline hydrochloride exhibits anti-HSV-1 activity, making it valuable for research applications in microbiology and virology.
  19. Polypeptide Antibiotic

    Colistin is a polypeptide antibiotic primarily targeting Gram-negative bacteria. It demonstrates potent activity against multidrug-resistant strains such as Pseudomonas aeruginosa, Acinetobacter baumannii, and Klebsiella pneumoniae. Due to its nephrotoxic potential, careful consideration is required during research. Colistin is valuable for studying infections caused by Gram-negative bacilli and exploring antibiotic resistance mechanisms.
  20. β-lactamase Inhibitor

    Clavulanate potassium is a potent β-lactamase inhibitor that enhances the effectiveness of β-lactam antibiotics by inhibiting bacterial enzyme activity. It is primarily used in research to study antimicrobial resistance mechanisms and to evaluate the synergy of antibiotic combinations. Clavulanate potassium is essential in elucidating bacterial adaptations and informing therapeutic strategies against resistant organisms.
  21. Antibiotic

    Penicillin V, also known as Phenoxymethylpenicillin, is a potent, orally bioavailable antibiotic targeting bacterial cell wall synthesis. It exhibits significant antibacterial activity against Streptococci, Clostridium difficile, and Staphylococcus aureus. This compound is valuable for research applications related to otitis, sinusitis, pharyngitis, and tonsillitis, providing insights into bacterial pathogenesis and resistance mechanisms.
  22. Antibiotic

    Cefacetrile is a broad-spectrum antibiotic with activity against both gram-positive and gram-negative bacteria. It targets bacterial cell wall synthesis, inhibiting peptidoglycan cross-linking, which leads to cell lysis and death. This compound is primarily utilized in research involving bacterial infections and offers valuable insights into antibiotic mechanisms and resistance.
  23. Lipoglycopeptide Antibiotic

    Dalbavancin is a semisynthetic lipoglycopeptide antibiotic targeting Gram-positive bacteria. It exhibits potent bactericidal activity, with minimal inhibitory concentrations (MIC90) of 0.06 μg/mL against Staphylococcus aureus and 0.25 μg/mL against Bacillus anthracis. This compound is primarily utilized in research applications focused on bacterial infections and the development of novel antimicrobial therapies.
  24. Antibiotic

    Micronomicin is an aminoglycoside antibiotic that exerts its effects primarily by binding to bacterial ribosomal RNA, leading to disruption of protein synthesis. This compound exhibits significant antibacterial and bactericidal activity against a wide range of Gram-negative and some Gram-positive bacteria. Micronomicin is utilized in research applications related to antibiotic resistance, infection models, and the study of microbial pathogenesis.
  25. β-lactamase Inhibitor

    Clavulanate lithium is a potent β-lactamase inhibitor that enhances the efficacy of β-lactam antibiotics by inhibiting bacterial enzymes responsible for antibiotic resistance. Its ability to combat antibiotic resistance makes it invaluable in research focused on understanding and overcoming treatment failures caused by resistant pathogens. Clavulanate lithium is commonly used in studies investigating the mechanisms of resistance and in the development of novel therapeutics.
  26. Antibiotic

    Telavancin hydrochloride is an antibiotic that functions primarily by inhibiting cell wall synthesis and disrupting cell membrane barrier function. This semisynthetic derivative of vancomycin demonstrates significant antibacterial activity against antibiotic-resistant Staphylococcus aureus strains, including MRSA, VISA, and hVISA. Telavancin hydrochloride is particularly effective in treating complicated skin and skin structure infections (cSSSI) caused by gram-positive bacteria. This compound is valuable for research into antibiotic resistance and the development of novel antimicrobial therapies.
  27. Antibacterial Agent

    Thiocarlide is an effective antibacterial agent primarily targeting Mycobacterium species. It demonstrates significant inhibitory activity against Mycobacterium tuberculosis H37Rv, Mycobacterium bovis BCG, Mycobacterium avium, and Mycobacterium aurum A+, with minimum inhibitory concentrations (MICs) of 2.5, 0.5, 2.0, and 2.0 μg/mL, respectively. Thiocarlide can be utilized in research applications focused on tuberculosis and other mycobacterial infections.
  28. Lincosamide Antibiotic

    Lincomycin is a lincosamide antibiotic that targets bacterial protein synthesis by inhibiting the 50S ribosomal subunit. It exhibits potent antimicrobial activity against a range of Gram-positive bacteria, making it invaluable in studying bacterial infections and resistance mechanisms. Lincomycin is commonly used in research applications focusing on microbial pathogenesis and the development of antibiotic resistance.
  29. Antibiotic

    Djalonensone is an antibiotic compound isolated from the roots of Anthocleista djalonensis (Loganiaceae). It exhibits significant antimicrobial activity, making it a valuable tool in research focused on developing new antibiotic therapies. Its unique properties also serve as an important taxonomic marker for the identification and classification of this plant species.
  30. Antibiotic

    Bleomycin B4 is an antibiotic that exhibits potent antitumor activity. It functions by inducing DNA strand breaks, leading to cell cycle arrest and apoptosis in cancer cells. This compound is commonly utilized in cancer research to explore therapeutic strategies and mechanisms of action in oncology.
  31. Antibacterial Agent

    Cyclacillin is an orally active aminopenicillin antibiotic that primarily targets bacterial cell wall synthesis. It exhibits significant antibacterial activity against a broad spectrum of gram-positive and gram-negative pathogens. This compound is useful in research applications focused on infection models and the study of antibiotic resistance mechanisms.
  32. Antibiotic

    Enduracidin is a polypeptide antibiotic that exerts its antibacterial effects by inhibiting cell wall synthesis in susceptible bacteria. Originally derived from Streptomyces fungicides, this compound is effective against a range of Gram-positive organisms. Enduracidin is primarily utilized in research applications focused on antibiotic resistance and the development of novel antibacterial agents.
  33. Antibacterial Agent

    Tellimagrandin II is an antibacterial agent that disrupts the integrity of the cell wall in Staphylococcus aureus, leading to cell lysis and loss of cytoplasmic contents. Additionally, it demonstrates anti-inflammatory properties and inhibits acetylcholinesterase (AChE), which may contribute to improvements in memory impairment. This compound is of interest in research focusing on antibacterial strategies, inflammatory pathways, and neurodegenerative conditions.
  34. Antibiotic

    Kasugamycin is an antibiotic that targets the ribosomal subunits by binding to both the 30S and 70S ribosomes, without interacting with isolated 50S subunits. It mimics mRNA nucleotides, leading to destabilization of tRNA binding and inhibition of canonical translation initiation. This compound is valuable for research in antibiotic mechanisms, ribosomal function, and the study of bacterial protein synthesis.
  35. Antibiotic

    Thiolactomycin is an antibiotic that targets the FabB enzyme, effectively inhibiting the synthesis of fatty acids and mycolic acids. This compound demonstrates potent activity against Gram-negative anaerobes and exhibits inhibitory effects on malaria parasites and trypanosomes. It is a valuable reagent for researchers investigating antibiotic mechanisms and fatty acid biosynthesis pathways, as well as for studies focused on protozoan infections.
  36. Polypeptide Antibiotics

    Polymyxin B2 is a polypeptide antibiotic that primarily targets the cell membrane of gram-negative bacteria. It exerts its antibacterial effect by binding to lipopolysaccharide components, leading to membrane disruption and subsequent cell lysis. This compound is relevant for antibiotic research and development, particularly in addressing drug-resistant bacterial strains.
  37. Macrolide Antibiotic

    Venturicidin A is a macrolide antibiotic that acts as a potent inhibitor of ATP synthase. Derived from actinomycetes, it enhances the efficacy of the aminoglycoside antibiotic gentamicin against multidrug-resistant strains of Staphylococcus, Enterococcus, and Pseudomonas aeruginosa. Although Venturicidin A demonstrates significant antibacterial activity, it also exhibits notable toxicity towards human embryonic kidney (HEK) cells, with an IC50 value of 31 μg/mL, making it a valuable compound for research in antibiotic resistance and cellular response assessments.
  38. Antibiotic

    Benzylideneacetone operates as an orally active antibiotic with a primary mechanism of inhibiting tyrosinase and phospholipase A2. It demonstrates antibacterial activity against select gram-negative plant-pathogenic bacteria, making it a valuable compound for agricultural research. Additionally, Benzylideneacetone serves as a versatile starting material in the synthesis of chemicals and pharmaceuticals, and it is utilized as a flavoring additive in certain food applications.
  39. Bacterial Inhibitor

    Flomoxef sodium is an oxacephem antibiotic that primarily targets bacterial ribosomes, inhibiting protein synthesis. It exhibits potent activity against a range of Gram-positive bacteria, making it suitable for research in antimicrobial resistance and bacterial infections. Flomoxef sodium can be utilized in studies exploring antibiotic efficacy and drug resistance mechanisms.
  40. Quinolone Antibiotic

    Nemonoxacin malate is a nonfluorinated quinolone antibiotic that targets bacterial DNA gyrase and topoisomerase IV. This compound demonstrates broad-spectrum antimicrobial activity against Gram-positive, Gram-negative, and atypical pathogens, including drug-resistant Streptococcus pneumoniae and Methicillin-resistant Staphylococcus aureus. Nemonoxacin malate is valuable for research focused on community-acquired pneumonia and other infections where antibiotic resistance is a concern.
  41. Bacterial Inhibitor

    Virginiamycin S1 is a cyclic hexadepsipeptide antibiotic that inhibits bacterial protein synthesis by targeting aminoacyl-tRNA binding and peptide bond formation. As a type B compound in the streptogramin family, it exhibits potent bactericidal activity against a diverse array of Gram-positive bacteria. Virginiamycin S1, particularly in combination with virginiamycin M1, is valuable in research focused on overcoming multidrug-resistant bacterial infections. Its application is relevant in fields such as microbiology and pharmacology, particularly in the study of antibiotic efficacy and resistance mechanisms.
  42. Antibacterial Agent

    Rosoxacin is an orally active broad-spectrum antibacterial quinolone antibiotic that primarily targets Gram-negative bacteria. It demonstrates effective inhibition against Neisseria gonorrhoeae, with a minimum inhibitory concentration (MIC) range of 0.03-0.125 µg/mL. This compound is valuable in research related to urinary tract infections and various sexually transmitted diseases, providing insights into bacterial resistance and treatment efficacy.
  43. Linker-Antibiotic Intermediate

    MC-VC-PAB-O-Gemcitabine is a linker-antibiotic intermediate specifically designed for use in antibody-antibiotic conjugate (AAC) applications. This compound features a conjugation with the antibiotic Gemcitabine, facilitating targeted delivery and enhancing the therapeutic potential against bacterial infections. Its utility in research encompasses the exploration of immunotherapy strategies and the development of novel antibacterial agents.
  44. Cephalosporin Antibiotic

    Ceftolozane TFA is a cephalosporin antibiotic that targets Gram-negative bacteria by disrupting cell wall synthesis. Its potent antibacterial activity makes it a valuable tool in combating resistant infections. Ceftolozane TFA can be utilized in research aimed at developing novel antibiotics with improved efficacy and safety profiles.
  45. Antibiotic Peptide

    Aurein 1.2 is an antibiotic peptide derived from amphibian sources, exhibiting potent antimicrobial and anticancer properties. This peptide targets bacterial membranes, leading to disruption and cell death, making it valuable in the study of antibiotic resistance and cancer therapeutics. Aurein 1.2 is ideal for research applications focused on the development of novel antimicrobial agents and exploring mechanisms of cancer cell apoptosis.
  46. Aminoglycoside Antibiotic

    Neamine is an aminoglycoside antibiotic and a degradation product of Neomycin, known for its broad-spectrum antibacterial properties. It exerts anti-angiogenic effects by targeting angiogenin, making it valuable in cancer research. Additionally, Neamine demonstrates neuroprotective and antitumor activities, supporting its potential in diverse biological studies.
  47. β-Lactam Antibiotic

    Cephalothin is a semi-synthetic cephalosporin antibiotic classified as a β-lactam antibiotic. It exerts its antibacterial activity by inhibiting class C β-lactamase AmpC with a Ki of 0.32 µM while also binding to penicillin-binding proteins, thereby disrupting the cross-linking of peptidoglycan in the bacterial cell wall. This mechanism impedes bacterial cell wall synthesis, allowing it to effectively target a broad spectrum of bacteria. Cephalothin is applicable in studies related to hematology and nephrotoxicity.
  48. Antibacterial Agent

    Targocil-II is an ABC transporter inhibitor demonstrating an IC50 value of 137 nM. By binding to allosteric sites within the transmembrane domain, Targocil-II effectively prevents ATP hydrolysis. This compound exhibits antibacterial activity, making it a valuable tool for research focused on combating multidrug resistance in bacterial pathogens.
  49. Antibacterial Agent

    CRS3123 dihydrochloride is a synthetic antibacterial agent that effectively targets methionyl-tRNA synthetase (MetRS) in Clostridioides difficile. By inhibiting MetRS, CRS3123 dihydrochloride reduces toxin production and spore formation associated with Clostridioides difficile infections (CDI). This compound serves as a valuable tool for research into CDI and potential therapeutic strategies.
  50. Cephem Antibiotic

    Cefcapene pivoxil hydrochloride is a pivalate ester prodrug of Cefcapene, functioning as a third-generation cephalosporin antibiotic. It demonstrates a broad spectrum of antibacterial activity, making it valuable in various microbiological studies. Additionally, this compound may hold potential for research applications related to palmoplantar pustulosis (PPP).

Items 3751-3800 of 6345

Page
per page
Set Descending Direction